humans |
54 |
female |
47 |
middle aged |
34 |
ovarian cancer |
34 |
adult |
33 |
aged |
27 |
pregnancy |
24 |
cervical cancer |
23 |
immunohistochemistry |
23 |
chemotherapy |
22 |
gestational trophoblastic disease |
22 |
gestational trophoblastic neoplasia |
20 |
prognosis |
20 |
hong kong - epidemiology |
19 |
human papillomavirus |
19 |
molecular sequence data |
19 |
genetic predisposition to disease |
18 |
adolescent |
17 |
animals |
17 |
cohort studies |
17 |
reverse transcriptase polymerase chain reaction |
17 |
aged, 80 and over |
16 |
choriocarcinoma |
16 |
neoplasm staging |
16 |
apoptosis |
15 |
cell proliferation |
15 |
gene expression regulation, neoplastic |
15 |
polymerase chain reaction |
15 |
risk factors |
15 |
cell line, tumor |
14 |
chinese |
14 |
hydatidiform mole |
14 |
antigens, cd - genetics |
13 |
base sequence |
13 |
cell adhesion molecules - genetics |
13 |
dna methylation |
13 |
l-lactate dehydrogenase - blood |
13 |
polymorphism, single nucleotide - genetics |
13 |
sensitivity and specificity |
13 |
breast cancer |
12 |
endometrial cancer |
12 |
hysterectomy |
12 |
tumor cells, cultured |
12 |
tumor markers, biological - analysis |
12 |
blotting, western |
11 |
brca1 protein - genetics |
11 |
case-control studies |
11 |
cell adhesion molecules - genetics - metabolism |
11 |
cercopithecus aethiops |
11 |
china |
11 |
cho cells - virology |
11 |
colposcopy |
11 |
coronavirus |
11 |
cricetinae |
11 |
cricetulus |
11 |
disease progression |
11 |
endometrial carcinoma |
11 |
homozygote |
11 |
intestine, small - physiology |
11 |
lectins, c-type - genetics - metabolism |
11 |
lung - physiology - virology |
11 |
medical sciences |
11 |
mutation - genetics |
11 |
promoter regions, genetic |
11 |
proteasome endopeptidase complex - metabolism |
11 |
receptors, cell surface - genetics - metabolism |
11 |
rna, messenger - metabolism |
11 |
sars coronavirus |
11 |
sars virus - metabolism - pathogenicity |
11 |
severe acute respiratory syndrome - epidemiology - genetics |
11 |
species index: animalia |
11 |
tandem repeat sequences |
11 |
vero cells - virology |
11 |
cervical screening |
10 |
dna, neoplasm - genetics |
10 |
gestational age |
10 |
hong kong |
10 |
leiomyosarcoma |
10 |
male |
10 |
ovarian neoplasms - genetics - metabolism - pathology |
10 |
prevalence |
10 |
transcription, genetic |
10 |
cervical intraepithelial neoplasia |
9 |
contrast-enhanced ct |
9 |
diagnosis, differential |
9 |
dna mutational analysis |
9 |
dna, viral - genetics |
9 |
drug resistance, neoplasm |
9 |
genes, tumor suppressor |
9 |
genotype |
9 |
ovarian neoplasms - genetics |
9 |
ovarian neoplasms - genetics - pathology |
9 |
phosphorylation |
9 |
screening |
9 |
survival analysis |
9 |
tumor markers, biological - metabolism |
9 |
carcinoma - genetics - pathology |
8 |
cell line, transformed |
8 |
cervical cancer screening |
8 |
choriocarcinoma - genetics |
8 |
dna hypermethylation |
8 |
dna primers |
8 |
epithelial ovarian cancer |
8 |
estrogen receptor alpha - genetics - metabolism |
8 |
genes, p53 - genetics |
8 |
gli1 |
8 |
hpv |
8 |
hydatidiform mole - genetics |
8 |
hydatidiform mole - genetics - pathology |
8 |
in situ nick-end labeling |
8 |
nuclear proteins - genetics - metabolism |
8 |
ovarian carcinoma |
8 |
p53 |
8 |
prognostic marker |
8 |
promoter regions, genetic - genetics |
8 |
retrospective studies |
8 |
signal transduction |
8 |
telomerase |
8 |
uterine neoplasms - genetics - pathology |
8 |
analgesia |
7 |
antigens, neoplasm |
7 |
asian continental ancestry group - genetics |
7 |
biopsy, needle |
7 |
breast neoplasms - epidemiology - genetics |
7 |
cell cycle proteins - analysis |
7 |
cell line |
7 |
cervix uteri - virology |
7 |
chromosome aberrations |
7 |
cisplatin - pharmacology |
7 |
diagnostic biomarker |
7 |
diffusion magnetic resonance imaging |
7 |
dna, mitochondrial - genetics |
7 |
dna-binding proteins |
7 |
ehealth |
7 |
epithelioid |
7 |
follow-up studies |
7 |
gene amplification |
7 |
gene expression profiling |
7 |
gene expression regulation, neoplastic - genetics |
7 |
genes, brca1 |
7 |
genes, brca2 |
7 |
genital neoplasms, female - metabolism - pathology |
7 |
gestational |
7 |
gestational trophoblastic disease - metabolism - pathology |
7 |
health economic analysis |
7 |
health literacy |
7 |
hedgehog |
7 |
hydatidiform mole - metabolism - pathology |
7 |
immunoenzyme techniques |
7 |
in situ hybridization |
7 |
karyotyping |
7 |
ki-67 antigen - analysis |
7 |
ki67 |
7 |
methylation |
7 |
microrna |
7 |
molar pregnancy |
7 |
morphine consumption |
7 |
mutation |
7 |
neoadjuvant chemotherapy |
7 |
neoplasm metastasis |
7 |
oncology |
7 |
ovarian neoplasms - metabolism - pathology |
7 |
ovary - pathology |
7 |
placebo |
7 |
placenta - metabolism |
7 |
polymorphism, genetic - genetics |
7 |
proliferation |
7 |
rct |
7 |
repressor proteins - biosynthesis |
7 |
self-sampling |
7 |
serms |
7 |
sex education |
7 |
sexual health |
7 |
somatic mutations |
7 |
transcription factors - genetics - metabolism |
7 |
trophoblastic |
7 |
tumors |
7 |
uterine cervical neoplasms |
7 |
women's health |
7 |
adenocarcinoma - genetics - metabolism - pathology |
6 |
anti-müllerian hormone |
6 |
apoptosis - drug effects - physiology |
6 |
asian continental ancestry group |
6 |
azacitidine - analogs & derivatives - pharmacology |
6 |
biopsy |
6 |
brca1 |
6 |
c-mos |
6 |
carcinogenesis |
6 |
carcinoma, squamous cell - genetics |
6 |
carcinoma, squamous cell - genetics - virology |
6 |
caspases - metabolism |
6 |
cell adhesion - physiology |
6 |
cell migration |
6 |
cell nucleus - metabolism |
6 |
cell proliferation - drug effects |
6 |
checkpoint inhibitor |
6 |
china - ethnology |
6 |
chromosome in situ hybridization |
6 |
cin |
6 |
combined modality therapy |
6 |
comparative genomic hybridization |
6 |
co‐testing |
6 |
cpg islands |
6 |
cyclin-dependent kinase inhibitor p21 |
6 |
differential gene expression |
6 |
dual specificity phosphatase 6 - antagonists & inhibitors - genetics - metabolism |
6 |
endometrial neoplasms - genetics - metabolism |
6 |
epigenesis, genetic |
6 |
estrogen receptors |
6 |
exons |
6 |
gene expression |
6 |
genes, p53 |
6 |
genital neoplasms, female - genetics |
6 |
germ cell tumor |
6 |
gynaecological cancer |
6 |
gynecological neoplasm |
6 |
hedgehog proteins - genetics - metabolism |
6 |
helix-loop-helix motifs |
6 |
high-grade tumor |
6 |
hpv testing |
6 |
hydrogen peroxide - metabolism |
6 |
id proteins |
6 |
immunotherapy |
6 |
inhibitor of differentiation protein 1 |
6 |
lymphadenectomy |
6 |
malignant ovarian germ cell tumors |
6 |
management |
6 |
metallothionein - genetics - metabolism |
6 |
metallothionein 1e gene |
6 |
metastasis |
6 |
mice |
6 |
microdissection |
6 |
microsatellite repeats - genetics |
6 |
mir-141 |
6 |
mitogen-activated protein kinase 1 - antagonists & inhibitors - metabolism |
6 |
mitogen-activated protein kinase 3 - antagonists & inhibitors - metabolism |
6 |
neoplasm proteins - genetics - metabolism |
6 |
neoplasm recurrence, local |
6 |
neoplasms |
6 |
nf-κb signaling |
6 |
observer variation |
6 |
oligonucleotide array sequence analysis |
6 |
ovarian neoplasms |
6 |
ovarian neoplasms - drug therapy - genetics - pathology |
6 |
ovarian neoplasms - drug therapy - pathology |
6 |
ovarian reserve |
6 |
oxidative stress - physiology |
6 |
p63 |
6 |
papillomaviridae - genetics |
6 |
papillomavirus infections - diagnosis - virology |
6 |
papillomavirus infections - epidemiology - ethnology - virology |
6 |
pd-l1 |
6 |
placenta - chemistry |
6 |
placenta - metabolism - pathology |
6 |
ploidies |
6 |
promoter hypermethylation |
6 |
proto-oncogene proteins c-mos - biosynthesis |
6 |
quality of life |
6 |
reproducibility of results |
6 |
reverse transcriptase polymerase chain reaction - methods |
6 |
rna, messenger - antagonists & inhibitors - genetics - metabolism |
6 |
rna, neoplasm - analysis |
6 |
sequence analysis, dna |
6 |
signal transduction - drug effects |
6 |
survival |
6 |
survival rate |
6 |
tak1 |
6 |
transcription factors - biosynthesis |
6 |
trophoblastic tumor |
6 |
trophoblastic tumor, placental site - genetics - metabolism - pathology |
6 |
trophoblasts - chemistry - pathology |
6 |
tumor suppressor protein p53 - analysis |
6 |
tumor suppressor proteins |
6 |
tumourigenicity |
6 |
ubiquitin - metabolism |
6 |
uterine cervical neoplasms - genetics |
6 |
uterine cervical neoplasms - genetics - metabolism - pathology |
6 |
uterine cervical neoplasms - pathology |
6 |
uterine neoplasms - genetics - metabolism - pathology |
6 |
uterus |
6 |
vaginal smears |
6 |
vulvar neoplasms - genetics - virology |
6 |
zic2 |
6 |
abdominal pregnancy |
5 |
acquired chemoresistance |
5 |
adenocarcinoma, clear cell - genetics - metabolism - pathology |
5 |
animal experiment |
5 |
animal model |
5 |
anoikis resistance |
5 |
antigens, polyomavirus transforming - genetics |
5 |
antimetabolites, antineoplastic - pharmacology |
5 |
antineoplastic-agents-pharmacology |
5 |
aorta |
5 |
apoptosis regulatory proteins |
5 |
apoptosis regulatory proteins - genetics - metabolism |
5 |
ascites |
5 |
biological markers - analysis |
5 |
blotting, northern |
5 |
blotting, western - methods |
5 |
blu |
5 |
breast cancer risk |
5 |
breast neoplasms - diagnosis - prevention & control |
5 |
breast neoplasms - genetics |
5 |
c-dna array |
5 |
calcium-calmodulin-dependent protein kinases - genetics |
5 |
cancer metabolism |
5 |
cancer prognosis |
5 |
cancer stem cell |
5 |
cancer survivorship |
5 |
carcinoma, endometrioid - enzymology - genetics |
5 |
carcinoma, endometrioid - enzymology - genetics - metabolism - pathology |
5 |
carcinoma, endometrioid - enzymology - genetics - pathology |
5 |
carcinoma, endometrioid - genetics - metabolism - pathology |
5 |
carcinoma, squamous cell - ethnology - genetics - virology |
5 |
carcinosarcoma |
5 |
cd55 |
5 |
cd8+ t cell |
5 |
cdna microarray |
5 |
cell culture techniques - methods |
5 |
cell cycle proteins |
5 |
cell cycle proteins - analysis - genetics |
5 |
cell differentiation |
5 |
cell division - drug effects |
5 |
cell invasion and proliferation |
5 |
cervical epithelial cells |
5 |
cervical intra-epithelial neoplasia |
5 |
cervical intraepithelial neoplasia - ethnology - genetics - virology |
5 |
cervix |
5 |
cervix uteri - chemistry - metabolism |
5 |
chemoradiotherapy |
5 |
chemoresistance |
5 |
choriocarcinoma-pathology |
5 |
chorionic gonadotropin - blood |
5 |
chromosome painting |
5 |
confidence intervals |
5 |
cyclin-dependent kinase inhibitor p21 - antagonists and inhibitors - genetics |
5 |
cystadenocarcinoma, mucinous - genetics - metabolism - pathology |
5 |
cystadenocarcinoma, serous - genetics - metabolism - pathology |
5 |
cytogenetic analysis - methods |
5 |
cytology |
5 |
dalys |
5 |
dapk |
5 |
decorin |
5 |
dichloroacetate dca |
5 |
dna replication |
5 |
dna, complementary - analysis |
5 |
dna, neoplasm |
5 |
dna, neoplasm - blood |
5 |
dna, neoplasm - chemistry - genetics - metabolism |
5 |
dna, viral - analysis |
5 |
dna-binding proteins - analysis |
5 |
dna-binding proteins - genetics - metabolism |
5 |
dnmt1 |
5 |
e-cadherin |
5 |
ectopic pregnancy |
5 |
endometrial neoplasms - enzymology - genetics |
5 |
endometrial neoplasms - enzymology - genetics - metabolism - pathology |
5 |
endometrial neoplasms - enzymology - genetics - pathology |
5 |
endometrial neoplasms - metabolism - pathology |
5 |
endometrial stromal sarcoma |
5 |
endometrium |
5 |
epithelial cells - cytology - metabolism |
5 |
evaluation studies as topic |
5 |
fear of cancer recurrence |
5 |
fibrosis |
5 |
forkhead transcription factors - analysis - genetics |
5 |
forkhead transcription factors - analysis - genetics - physiology |
5 |
foxg1 |
5 |
foxm1 |
5 |
gene expression regulation, enzymologic |
5 |
gene expression regulation, neoplastic - radiation effects |
5 |
gene frequency |
5 |
genes, p16 |
5 |
genes, ras |
5 |
genes, viral - genetics |
5 |
genetic predisposition to disease - genetics |
5 |
genitalia, female - cytology |
5 |
genotyping |
5 |
gestational trophoblastic disease - genetics - metabolism - pathology |
5 |
gestational trophoblastic disease - genetics - pathology |
5 |
glutathione s-transferase pi |
5 |
glutathione transferase - analysis - genetics - metabolism |
5 |
glutathione transferase - genetics |
5 |
grb7 |
5 |
gynecological cancer |
5 |
hdab2ip |
5 |
health care surveys |
5 |
hemoperitoneum |
5 |
hereditary breast cancer |
5 |
hexokinase ii |
5 |
hormonal treatment |
5 |
hpv-negative |
5 |
hpv‐e6 |
5 |
human papillomavirus 16 - genetics |
5 |
human papillomavirus 18 - genetics |
5 |
hydatidiform mole - diagnosis - genetics - pathology |
5 |
hydatidiform mole - genetics - pathology - surgery |
5 |
iatrogenesis |
5 |
iatrogenic disease - epidemiology |
5 |
immortalization |
5 |
immunohistochemical staining |
5 |
in situ hybridization - methods |
5 |
in vitro culture |
5 |
inflammation |
5 |
interval debulking surgery |
5 |
intracellular signaling peptides and proteins |
5 |
isoenzymes - genetics |
5 |
jag1-notch1 |
5 |
keratins - metabolism |
5 |
ki-67 antigen - biosynthesis |
5 |
klf12 |
5 |
leiomyoma with bizarre nuclei |
5 |
logistic models |
5 |
loss of heterozygosity |
5 |
magnetic resonance imaging |
5 |
mass screening - utilization |
5 |
mcl-1 |
5 |
mcm7 |
5 |
mdm2 |
5 |
metastatic partial mole |
5 |
mgmt |
5 |
microsatellite repeats |
5 |
minichromosome maintenance protein 7 (mcm7) |
5 |
mir-199b-5p |
5 |
multivariate analysis |
5 |
neo-adjuvant chemotherapy |
5 |
neoplasm invasiveness |
5 |
nerve tissue proteins - analysis - genetics - physiology |
5 |
nuclear proteins |
5 |
nuclear proteins - analysis |
5 |
o(6)-methylguanine-dna methyltransferase - genetics |
5 |
obstetrics and gynecology medical sciences |
5 |
odds ratio |
5 |
oncogenes - genetics |
5 |
ovarian neoplasms - pathology |
5 |
ovary |
5 |
ovary - metabolism - pathology |
5 |
oviduct |
5 |
oxidoreductases |
5 |
p-p53 (ser15) |
5 |
p16 |
5 |
p16ink4a |
5 |
p21waf1/cip1 |
5 |
palb2 mutation |
5 |
papillomaviridae |
5 |
papillomaviridae - classification - isolation & purification |
5 |
papillomaviridae - isolation & purification |
5 |
papillomavirus infections - ethnology - genetics |
5 |
patient-initiated follow-up |
5 |
pcna |
5 |
pd-1 |
5 |
pdk1 |
5 |
peritoneal dialysis |
5 |
peritonitis |
5 |
pet/ct |
5 |
phenotype |
5 |
phosphohistone-h3 |
5 |
placenta - anatomy & histology |
5 |
polymorphism, genetic |
5 |
polymorphism, restriction fragment length |
5 |
polymorphism, single nucleotide |
5 |
precancerous conditions - ethnology - genetics - virology |
5 |
probability |
5 |
proliferating cell nuclear antigen - biosynthesis |
5 |
promoter cpg island hypermethylation |
5 |
proteins - genetics |
5 |
proteins - metabolism |
5 |
proto-oncogene proteins c-bcl-2 - genetics - metabolism |
5 |
public health and safety |
5 |
pyruvate kinase |
5 |
random cervical biopsy |
5 |
ras gtpase-activating proteins - metabolism |
5 |
rassf1a |
5 |
rassf2a |
5 |
repressor proteins - metabolism |
5 |
reproduction |
5 |
rna, messenger - genetics - metabolism |
5 |
smooth muscle tumour of uncertain malignant potential |
5 |
sp1 |
5 |
squamous intraepithelial lesion |
5 |
standardized uptake value |
5 |
statistics, nonparametric |
5 |
stemness |
5 |
supportive care needs |
5 |
survivin |
5 |
t cells |
5 |
tgf-β |
5 |
tissue array analysis |
5 |
tissue microarray |
5 |
transfection |
5 |
transforming growth factor beta - pharmacology |
5 |
tretinoin-pharmacology |
5 |
trophoblastic neoplasms - metabolism - pathology |
5 |
tumor markers, biological - genetics |
5 |
tumor suppressor proteins - metabolism |
5 |
tumor virus infections - diagnosis |
5 |
up-regulation |
5 |
uterine cervical neoplasms - blood - enzymology - genetics |
5 |
uterine cervical neoplasms - diagnosis - prevention & control |
5 |
uterine cervical neoplasms - ethnology - genetics - virology |
5 |
uterine neoplasms |
5 |
uterine neoplasms - diagnosis - genetics - pathology |
5 |
uterine neoplasms - genetics - pathology - surgery |
5 |
uterine neoplasms - metabolism - pathology |
5 |
uterine sarcoma |
5 |
vin |
5 |
viral dna integration |
5 |
virus integration - genetics |
5 |
vulvar cancer |
5 |
vulvar dystrophy |
5 |
young adult |
5 |
2-[18f]fdg pet/ct |
4 |
adaptor proteins, signal transducing - genetics |
4 |
adenocarcinoma - enzymology |
4 |
adenocarcinoma - genetics |
4 |
adenocarcinoma - metabolism - pathology |
4 |
akt |
4 |
alleles |
4 |
amp-activated protein kinases |
4 |
ampk |
4 |
ampk activation |
4 |
ampk-β1 |
4 |
animal modelanimal tissue |
4 |
antibodies - pharmacology |
4 |
antineoplastic combined chemotherapy protocols - adverse effects - therapeutic use |
4 |
antineoplastic combined chemotherapy protocols - therapeutic use |
4 |
apoptosis - genetics - physiology |
4 |
atr-chk1 |
4 |
autophagy |
4 |
b-catenin |
4 |
bcl-2-associated x protein |
4 |
bd onclarity |
4 |
beta catenin - metabolism |
4 |
blotting, southern |
4 |
brca-negative |
4 |
brca2 protein |
4 |
c-33 a cell line |
4 |
c-4-i cell line |
4 |
c-erbb2 |
4 |
ca 125 |
4 |
cadherin-11 |
4 |
cadherins - antagonists and inhibitors - genetics - physiology |
4 |
cadherins - biosynthesis - metabolism |
4 |
cancer aggressiveness |
4 |
cancer cell |
4 |
cancer stem cells |
4 |
cancer-associated fibroblasts |
4 |
candidate cancer genes |
4 |
carcinoma, hepatocellular - pathology - surgery |
4 |
carcinoma, squamous cell - diagnosis - enzymology - virology |
4 |
carcinoma, squamous cell - enzymology |
4 |
caspases-biosynthesis |
4 |
catenins - genetics - metabolism - physiology |
4 |
catheter ablation |
4 |
cell cycle |
4 |
cell invasion |
4 |
cell migration and invasion |
4 |
cell movement |
4 |
centromere |
4 |
cervical cancers |
4 |
cervical cytology |
4 |
cervical intraepithelial neoplasia - diagnosis - enzymology - pathology - virology |
4 |
cervical smear |
4 |
cervix uteri - metabolism |
4 |
chamoc regimen |
4 |
chemokines |
4 |
chemotherapy response score |
4 |
choriocarcinoma - genetics - metabolism |
4 |
choriocarcinoma - genetics - pathology |
4 |
choriocarcinoma-enzymology |
4 |
chorionic gonadotropin, beta subunit, human - metabolism |
4 |
chromosomal proteins, non-histone - genetics |
4 |
chromosome |
4 |
chromosomes, human, pair 11 |
4 |
chromosomes, human, pair 12 |
4 |
chromosomes, human, pair 17 |
4 |
chromosomes, human, pair 5 - genetics |
4 |
cisplatin |
4 |
cisplatin resistance |
4 |
clear cell |
4 |
cloning, molecular |
4 |
compliance |
4 |
concurrent methylation |
4 |
cross-sectional studies |
4 |
cxcr2 |
4 |
cytogenetic study |
4 |
cytogenetics |
4 |
cytoplasm - enzymology |
4 |
death- associated protein kinase |
4 |
demethylating agents |
4 |
disease-free survival |
4 |
dna - chemistry |
4 |
dna modification methylases - antagonists & inhibitors |
4 |
dna primers - chemistry |
4 |
dna primers - genetics |
4 |
dna, complementary - metabolism |
4 |
dna, neoplasm - metabolism |
4 |
dna-directed dna polymerase - genetics |
4 |
down-regulation |
4 |
duoxa1 |
4 |
education |
4 |
educational status |
4 |
endometrial cancers |
4 |
endometrial neoplasms - genetics |
4 |
endometrial neoplasms - genetics - metabolism - pathology |
4 |
endometrial neoplasms - genetics - pathology - ultrastructure |
4 |
endometrial neoplasms - pathology - physiopathology |
4 |
enzyme inhibitors - pharmacology |
4 |
epigenesis, genetic - physiology |
4 |
epigenetic |
4 |
epithelial cells - pathology |
4 |
erk |
4 |
estradiol - pharmacology |
4 |
estrogen receptor beta - genetics - metabolism |
4 |
extravillous trophoblast |
4 |
eye proteins - antagonists & inhibitors - genetics - pharmacology |
4 |
fak/erk signaling |
4 |
fallopian tube |
4 |
fallopian tube neoplasms - pathology |
4 |
filter‐in‐situ hybridization |
4 |
first-trimester |
4 |
follistatin-related proteins - genetics - physiology |
4 |
follow‐up |
4 |
forkhead transcription factor |
4 |
founder effect |
4 |
foxo3a |
4 |
gene dosage |
4 |
gene expression - drug effects |
4 |
gene expression profiling - methods |
4 |
gene expression regulation, neoplastic - drug effects |
4 |
gene-expression-regulation,-neoplastic |
4 |
general gynaecology |
4 |
genetic markers |
4 |
genetics, population |
4 |
genome, human |
4 |
genomic instability - genetics |
4 |
germ-line mutation - genetics |
4 |
gestational trophoblastic disease - genetics |
4 |
gestational trophoblastic diseases |
4 |
gestational trophoblastic neoplasms - genetics - pathology - therapy |
4 |
gnrh |
4 |
gpi-linked proteins |
4 |
gro-α |
4 |
gtp-binding proteins - metabolism |
4 |
gynecologic cancer |
4 |
gynecologic oncology |
4 |
gynecological cancers |
4 |
health knowledge, attitudes, practice |
4 |
health surveys |
4 |
hedgehog proteins - metabolism |
4 |
hela cells |
4 |
hepatitis c - complications |
4 |
hepatitis c virus |
4 |
hepatocellular carcinoma |
4 |
high throughput screen |
4 |
high-grade squamous intraepithelial lesions |
4 |
high-risk gestational trophoblastic disease |
4 |
hippo/yap1/pathway |
4 |
hk2 |
4 |
homeodomain proteins - genetics - metabolism |
4 |
hpv vaccine |
4 |
hpv vaccine perception |
4 |
hpv vaccine questionnaire |
4 |
hpv vaccine survey |
4 |
human papilloma virus (hpv) |
4 |
human papillomavirus infection (hpv‐1) |
4 |
hydatidiform mole - genetics - metabolism - pathology |
4 |
hydatidiform mole - metabolism |
4 |
hydatidiform-mole-chemistry |
4 |
hydroxamic acids - pharmacology |
4 |
igf-1r |
4 |
igfbp3 |
4 |
il-8 |
4 |
interphase |
4 |
isothermal amplification |
4 |
jnk |
4 |
laparoscopic |
4 |
laparoscopy |
4 |
laparotomy |
4 |
liver neoplasms - pathology - surgery |
4 |
low-grade squamous intraepithelial lesions |
4 |
ly294002 |
4 |
mapk signaling |
4 |
mass screening - methods |
4 |
membrane glycoproteins - genetics - metabolism |
4 |
metformin |
4 |
methylation profile |
4 |
methylome profiling |
4 |
microsatellite instability analysis |
4 |
microwave coagulation |
4 |
microwaves - therapeutic use |
4 |
mir-193a-3p |
4 |
mismatch repair deficiency |
4 |
mitochondrial dna |
4 |
mitochondrial microsatellite instability |
4 |
molecular diagnostic techniques - methods |
4 |
motility |
4 |
mtor |
4 |
multienzyme complexes - genetics |
4 |
multigene panel |
4 |
nanog |
4 |
neoplasm proteins - analysis |
4 |
neoplasm proteins - genetics |
4 |
neoplasm proteins - metabolism |
4 |
neoplasm, residual |
4 |
neoplastic stem cells - physiology |
4 |
nerve growth factors - antagonists & inhibitors - genetics - pharmacology |
4 |
nfκb signaling |
4 |
notch |
4 |
nuclear proteins - genetics |
4 |
nurr1 |
4 |
oct4 |
4 |
octamer transcription factor-3 - genetics - metabolism |
4 |
oncogene proteins, viral - biosynthesis |
4 |
osteopontin |
4 |
ovarian neoplasms - enzymology - genetics - pathology |
4 |
ovarian neoplasms - genetics - metabolism |
4 |
ovarian neoplasms - pathology - physiopathology |
4 |
ovarian tumors |
4 |
ovary - cytology - metabolism |
4 |
ovary - metabolism |
4 |
ovary cancer |
4 |
p-cadherin |
4 |
p120ctn |
4 |
p21-activated kinases - antagonists and inhibitors - genetics - physiology |
4 |
pak1 |
4 |
pak2 |
4 |
papillomaviridae - classification - genetics - isolation and purification |
4 |
papillomaviridae - immunology |
4 |
papillomavirus e7 proteins |
4 |
papillomavirus infections - complications - enzymology - genetics |
4 |
papillomavirus infections - prevention & control - virology |
4 |
papillomavirus vaccines |
4 |
peritoneal metastases |
4 |
peritoneal neoplasms |
4 |
pilot projects |
4 |
placenta |
4 |
placenta - cytology |
4 |
placenta - physiology |
4 |
placenta-chemistry |
4 |
placental site |
4 |
placental site trophoblastic tumor |
4 |
placental-site tro phoblastic tumor |
4 |
polymerase chain reaction - methods |
4 |
prediction model |
4 |
predictive value of tests |
4 |
pregnancy complications, infectious - diagnosis - enzymology - virology |
4 |
pregnancy complications, infectious - epidemiology - pathology |
4 |
pregnancy complications, neoplastic - pathology |
4 |
pregnancy trimester, first |
4 |
pregnancy trimester, third - genetics |
4 |
pregnancy trimesters |
4 |
primary care |
4 |
prkaa1 |
4 |
promoter regions (genetics) |
4 |
prospective studies |
4 |
prostate stem cell antigen |
4 |
prostatic neoplasms - genetics - metabolism - pathology |
4 |
protein-serine-threonine kinases - genetics |
4 |
proto-oncogene proteins c-bcl-2 - metabolism |
4 |
proto-oncogene-proteins-c-myc-analysis |
4 |
psychological well-being |
4 |
questionnaires |
4 |
radiation tolerance - genetics |
4 |
radio waves |
4 |
radiofrequency ablation |
4 |
radioresistance |
4 |
receptor, erbb-2 - metabolism |
4 |
receptor, igf type 1 - antagonists and inhibitors - genetics - physiology |
4 |
receptor,-macrophage-colony-stimulating-factor-analysis |
4 |
receptors, cell surface - metabolism |
4 |
receptors, fsh - genetics |
4 |
recurrence of hcc |
4 |
rho gtp-binding proteins - metabolism |
4 |
rna - metabolism |
4 |
rna, messenger - analysis |
4 |
rna, messenger - biosynthesis - genetics |
4 |
rna, small interfering - pharmacology |
4 |
rna-binding proteins - genetics - metabolism |
4 |
robot-assisted |
4 |
ros |
4 |
sarcoma, endometrial stromal - genetics - pathology - ultrastructure |
4 |
self-renewal |
4 |
semi-quantitative fluorescent differential pcr |
4 |
sentis hpv |
4 |
serpins - genetics - pharmacology |
4 |
sialoglycoproteins - metabolism |
4 |
signal transduction - genetics |
4 |
signal transduction - physiology |
4 |
sox7 |
4 |
spain - epidemiology |
4 |
squamous cell carcinoma |
4 |
stat3 |
4 |
stat3 transcription factor - biosynthesis - genetics - metabolism |
4 |
sulfites - chemistry |
4 |
suppression subtractive hybridization |
4 |
surgery |
4 |
tamoxifen |
4 |
telomerase - analysis |
4 |
telomerase - metabolism |
4 |
telomerase repeat amplification protocol |
4 |
telomere - enzymology - genetics |
4 |
temperature |
4 |
tgfβ |
4 |
therapeutic molecular target |
4 |
therapeutic target |
4 |
time factors |
4 |
transcription factors - genetics |
4 |
transcription factors - metabolism |
4 |
transforming growth factor beta - physiology |
4 |
transforming growth factor beta1 |
4 |
treatment outcome |
4 |
trf |
4 |
trophoblasts - physiology |
4 |
trophoblasts-chemistry |
4 |
tumor grading |
4 |
tumor suppressor genes |
4 |
tumor suppressor protein p53 - genetics - metabolism |
4 |
tumor virus infections - epidemiology - pathology |
4 |
tumor-stroma interactions |
4 |
uterine cervical diseases - microbiology |
4 |
uterine cervical dysplasia - diagnosis - enzymology - pathology - virology |
4 |
uterine cervical neoplasms - diagnosis - enzymology - pathology - virology |
4 |
uterine cervical neoplasms - enzymology |
4 |
uterine cervical neoplasms - enzymology - genetics - virology |
4 |
uterine cervical neoplasms - metabolism - radiotherapy |
4 |
uterine cervical neoplasms - prevention & control - virology |
4 |
uterine cervicitis - enzymology - pathology - virology |
4 |
uterine cervix |
4 |
uterine leiomyosarcoma |
4 |
uterine neoplasms - genetics - metabolism |
4 |
uterine-neoplasms-enzymology |
4 |
venous thromboembolism |
4 |
x chromosome |
4 |
18f-fdg pet/ct |
3 |
abdominal hysterectomy |
3 |
abortion, spontaneous |
3 |
abortion, spontaneous - immunology |
3 |
abortion, spontaneous - metabolism |
3 |
actin |
3 |
actins - metabolism - ultrastructure |
3 |
adaptor proteins, signal transducing - genetics - metabolism |
3 |
adenocarcinoma |
3 |
adenocarcinoma - pathology |
3 |
adenocarcinoma, clear cell - drug therapy - pathology - radiotherapy |
3 |
adenocarcinoma, clear cell - genetics - pathology |
3 |
adenocarcinoma, clear cell - pathology - therapy |
3 |
adenocarcinoma, mucinous - diagnosis - pathology - therapy - ultrastructure |
3 |
adenomyosis |
3 |
adjuvants |
3 |
age factors |
3 |
aicar |
3 |
ais |
3 |
alphapapillomavirus - isolation and purification |
3 |
alternative splicing |
3 |
amp-activated protein kinase |
3 |
ampk alpha 2 |
3 |
ampk subunits |
3 |
antigens, neoplasm - metabolism |
3 |
antineoplastic agents - therapeutic use |
3 |
antineoplastic agents, phytogenic - pharmacology |
3 |
antineoplastic combined chemotherapy protocols - administration & dosage |
3 |
anxiety - etiology |
3 |
apoferritins |
3 |
apoptosis - physiology |
3 |
apoptosis - physiology - radiation effects |
3 |
apoptosis regulatory proteins - genetics - metabolism - physiology |
3 |
apoptotic (ai) and mitotic indices (mi) |
3 |
apoptotic activity |
3 |
asian continental ancestry group - ethnology |
3 |
asian women |
3 |
aspp1 |
3 |
attitude to health |
3 |
atypical cytology |
3 |
bcl2a1 |
3 |
beliefs |
3 |
beta-catenin |
3 |
bitter melono |
3 |
brachytherapy - methods |
3 |
brain-derived neurotrophic factor - biosynthesis |
3 |
brenner tumor - diagnosis - metabolism - pathology |
3 |
brenner tumour |
3 |
c-erbb-2 |
3 |
c-fms |
3 |
c-kit |
3 |
c-myc |
3 |
ca-125 antigen - blood |
3 |
ca125 |
3 |
camkk |
3 |
cancer |
3 |
cancer cell growth |
3 |
cancer radiotherapy |
3 |
cancer screening |
3 |
carboplatin |
3 |
carcinoid tumor - diagnosis - pathology - therapy - ultrastructure |
3 |
carcinoma |
3 |
carcinoma - enzymology - mortality - pathology |
3 |
carcinoma in situ - pathology |
3 |
carcinoma of cervix |
3 |
carcinoma, endometrioid - chemistry - pathology |
3 |
carcinoma, non-small-cell lung - genetics - metabolism - pathology |
3 |
carcinoma, squamous cell - diagnosis - genetics |
3 |
carcinoma, squamous cell - genetics - mortality - surgery - virology |
3 |
carcinoma, squamous cell - metabolism - mortality - virology |
3 |
carcinoma, squamous cell - pathology |
3 |
carcinoma, squamous cell - pathology - radiotherapy - surgery |
3 |
carcinoma, transitional cell - diagnosis - metabolism - pathology |
3 |
carcinoma,-squamous-cell-metabolism |
3 |
caspase |
3 |
cathepsin d |
3 |
cathepsin d - chemistry |
3 |
cdc42 |
3 |
cell cycle - physiology |
3 |
cell division |
3 |
cell movement - genetics |
3 |
cell movement - physiology |
3 |
cell signaling |
3 |
cell transformation, neoplastic - genetics |
3 |
cell transformation, viral - genetics |
3 |
cervical carcinoma and prognosis |
3 |
cervical intraepithelial neoplasia - genetics - metabolism |
3 |
cervix uteri - microbiology |
3 |
cervix uteri - pathology - radiation effects |
3 |
cervix uteri - pathology - virology |
3 |
chemoirradiation |
3 |
chi-square distribution |
3 |
chinese women |
3 |
choriocarcinoma - complications - surgery |
3 |
choriocarcinoma - diagnosis - immunology |
3 |
choriocarcinoma - genetics - metabolism - pathology |
3 |
choriocarcinoma - metabolism |
3 |
choriocarcinoma, non-gestational - pathology - therapy |
3 |
choriocarcinomas |
3 |
chorionic gonadotropin - metabolism |
3 |
chromosomes, human, pair 11 - genetics |
3 |
chromosomes, human, pair 16 - genetics |
3 |
chromosomes, human, pair 17 - genetics |
3 |
clear cell adenocarcinoma |
3 |
clear cell carcinoma |
3 |
comparative genomic hybridisation |
3 |
copy number |
3 |
cyclin-dependent kinase inhibitor p21 - metabolism |
3 |
cyclind1 |
3 |
cyclins - metabolism |
3 |
cyclophosphamide - administration & dosage - adverse effects |
3 |
cystadenocarcinoma, mucinous - genetics - pathology |
3 |
cystadenocarcinoma, serous - chemistry - pathology |
3 |
cystadenocarcinoma, serous - genetics - pathology |
3 |
cystadenoma - enzymology - mortality - pathology |
3 |
cystadenoma, mucinous - chemistry - pathology |
3 |
cystadenoma, serous - chemistry - pathology |
3 |
cytoskeleton - metabolism - ultrastructure |
3 |
d-loop |
3 |
daidzein |
3 |
diffusion |
3 |
diffusion-weighted mri |
3 |
dinucleotide repeats |
3 |
dj-1 |
3 |
dna amplification |
3 |
dna replication - genetics |
3 |
dna topoisomerases, type ii - analysis |
3 |
dna, complementary - genetics |
3 |
dna, mitochondrial - blood - genetics |
3 |
dna, mitochondrial - genetics - isolation & purification - metabolism |
3 |
dna, mitochondrial - genetics - metabolism |
3 |
dna, neoplasm - blood - genetics |
3 |
dna-binding proteins - biosynthesis - genetics |
3 |
dock180 expression |
3 |
drugs, chinese herbal - adverse effects - therapeutic use |
3 |
e2 binding sites methylation |
3 |
egfr |
3 |
endometrial neoplasms - pathology |
3 |
endometrial neoplasms - virology |
3 |
endometriosis |
3 |
endometriosis - diagnosis - pathology |
3 |
enzymes - genetics |
3 |
epidermal growth factor receptor |
3 |
epithelial cells |
3 |
epithelial cells - metabolism - pathology |
3 |
epithelioid cells - drug effects - pathology |
3 |
epithelioid trophoblastc tumour |
3 |
erb-041 |
3 |
esophageal neoplasms - genetics - mortality - surgery - virology |
3 |
esophagectomy |
3 |
esophagus - virology |
3 |
fallopian tubes - pathology |
3 |
ferritins |
3 |
fgf9 |
3 |
filter in-situ-hybridization |
3 |
follow-up |
3 |
ftl |
3 |
gemcitabine |
3 |
gene deletion |
3 |
gene knockdown techniques |
3 |
genes,-p53-genetics |
3 |
genistein |
3 |
genital neoplasms, female - epidemiology - pathology |
3 |
globins - genetics |
3 |
grb7 adaptor protein - genetics - metabolism - physiology |
3 |
green fluorescent proteins - genetics - metabolism |
3 |
gynecologic surgical procedures |
3 |
hormone receptors |
3 |
hpv infection |
3 |
hpv vaccination |
3 |
human papillomavirus (hpv) 16 |
3 |
human papillomavirus (hpv) 18 |
3 |
human papillomavirus 16 |
3 |
human papillomavirus 18 |
3 |
hydatidiform mole - blood - complications - drug therapy - surgery |
3 |
hydatidiform mole - diagnosis - immunology |
3 |
hydatidiform mole - enzymology |
3 |
hydatidiform mole - genetics - metabolism |
3 |
hydatidiform mole - immunology - pathology |
3 |
hypermethylation |
3 |
hypoxia |
3 |
igfbp1 |
3 |
immune function |
3 |
immunologic |
3 |
immunology |
3 |
incidence |
3 |
individuality |
3 |
infant, newborn |
3 |
inhibitor of apoptotic protein (iap) |
3 |
insulin-like growth factor binding protein 1 - genetics |
3 |
intracellular signaling peptides and proteins - genetics |
3 |
intravoxel incoherent motion |
3 |
intrinsic cell apoptosis |
3 |
invasion |
3 |
irradiation |
3 |
isoenzymes - genetics - metabolism |
3 |
ki-67 antigen |
3 |
ki-67 index |
3 |
knowledge |
3 |
laser capture microdissection |
3 |
leep |
3 |
liquid-based cervical cytology |
3 |
lkb1 |
3 |
lletz |
3 |
longitudinal |
3 |
lung neoplasms - genetics - metabolism - pathology |
3 |
lymphocytes - metabolism |
3 |
m30 |
3 |
macrophage polarization |
3 |
malignant melanoma |
3 |
map30 |
3 |
matrix metalloproteinase 14 - genetics - metabolism |
3 |
melanoma - epidemiology - pathology |
3 |
membrane proteins - biosynthesis |
3 |
membrane proteins - biosynthesis - genetics |
3 |
membrane proteins - genetics - metabolism |
3 |
mesoderm - metabolism - pathology |
3 |
metabolism |
3 |
methotrexate |
3 |
mi/ai ratio |
3 |
microsatellite instability |
3 |
microscopy, confocal |
3 |
mirna |
3 |
mitochondria - genetics |
3 |
mitogen-activated protein kinases - antagonists and inhibitors - metabolism |
3 |
mitosis - drug effects |
3 |
mitotic index |
3 |
mole |
3 |
monotherapy |
3 |
mucin |
3 |
mucins - secretion |
3 |
mullerian duct |
3 |
mutation- |
3 |
neoplasm grading |
3 |
neoplasm invasiveness - genetics - pathology |
3 |
neoplasm invasiveness - pathology |
3 |
neoplasm proteins - analysis - immunology |
3 |
neoplasm proteins/genetics |
3 |
neoplasm recurrence, local - pathology |
3 |
neoplasms, multiple primary - diagnosis - pathology - therapy - ultrastructure |
3 |
neovascularization, pathologic - genetics - metabolism |
3 |
neuroendocrine and mucinous carcinoma |
3 |
non-small cell lung cancer |
3 |
nongestatational choriocarcinoma |
3 |
normal cervix |
3 |
nr4a2 |
3 |
nuclear proteins - biosynthesis - genetics |
3 |
nuclear proteins - immunology - metabolism |
3 |
oligonucleotide array sequence analysis - methods |
3 |
oncogene proteins - biosynthesis - genetics |
3 |
oncogenes |
3 |
ovarian and peritoneal cancers |
3 |
ovarian cancer recurrence |
3 |
ovarian neoplasms - chemistry - pathology |
3 |
ovarian neoplasms - diagnosis - metabolism - pathology |
3 |
ovarian neoplasms - diagnosis - pathology - therapy - ultrastructure |
3 |
ovarian neoplasms - drug therapy - immunology |
3 |
ovarian neoplasms - drug therapy - metabolism - pathology |
3 |
ovarian neoplasms - enzymology - mortality - pathology |
3 |
ovarian neoplasms - enzymology - pathology |
3 |
ovarian neoplasms - metabolism - mortality - pathology |
3 |
ovarian neoplasms - pathology - therapy |
3 |
ovarian neoplasms - virology |
3 |
ovarian tumor |
3 |
ovarian tumours |
3 |
ovary - cytology |
3 |
p21(waf1/cip1) |
3 |
p21-activated kinases - antagonists and inhibitors - genetics - metabolism |
3 |
p21-activated kinases - genetics - metabolism |
3 |
p53 arg-72 |
3 |
p53 codon 72 polymorphism |
3 |
p70 s6 kinase |
3 |
p73 |
3 |
paclitaxel |
3 |
paclitaxel - pharmacology |
3 |
pan-ras |
3 |
papillomaviridae - genetics - isolation & purification |
3 |
papillomavirus infections - complications - epidemiology - virology |
3 |
papillomavirus infections - diagnosis - psychology |
3 |
papillomavirus infections - epidemiology - mortality |
3 |
papillomavirus infections - ethnology - prevention & control |
3 |
papillomavirus infections - ethnology - prevention & control - psychology |
3 |
papillomavirus vaccines - therapeutic use |
3 |
patient acceptance of health care |
3 |
patient acceptance of health care - ethnology |
3 |
patient satisfaction - ethnology |
3 |
pelvic neoplasms - diagnosis - pathology |
3 |
peptides - genetics |
3 |
perfusion |
3 |
peritoneal carcinomatosis |
3 |
peritoneal metastasis |
3 |
physical examination |
3 |
placenta - cytology - metabolism - pathology |
3 |
placenta - enzymology |
3 |
placenta - immunology - pathology |
3 |
placental site trophoblastic tumour |
3 |
polymorphism, single-stranded conformational |
3 |
post lletz complications |
3 |
precancerous conditions - diagnosis - genetics |
3 |
pregnancy complications - metabolism - pathology |
3 |
pregnancy complications, neoplastic - genetics |
3 |
premetastatic niche |
3 |
prevention |
3 |
prognostic factor |
3 |
prognostic factors |
3 |
proliferating cell nuclear antigen |
3 |
proto-oncogenes - physiology |
3 |
psychology |
3 |
psychosocial adjustment |
3 |
pten |
3 |
pten phosphohydrolase - biosynthesis - genetics |
3 |
rac gtp-binding proteins - analysis - biosynthesis |
3 |
rac1 |
3 |
radiation tolerance - genetics - physiology |
3 |
rare diseases |
3 |
real-time polymerase chain reaction |
3 |
real-time quantitative pcr |
3 |
receptor, epidermal growth factor - metabolism |
3 |
receptor, trkb - biosynthesis |
3 |
receptors, estrogen - chemistry |
3 |
receptors, progesterone - chemistry |
3 |
repressor proteins |
3 |
repressor proteins - biosynthesis - genetics |
3 |
ribonuclease protection assay |
3 |
ribosomal protein s6 kinases, 70-kda - genetics - metabolism |
3 |
ribosomal protein s6 kinases, 70-kda - physiology |
3 |
risk assessment |
3 |
rna |
3 |
rna, ribosomal - genetics |
3 |
rna, ribosomal, 16s - genetics |
3 |
rna, small interfering |
3 |
rna-binding proteins - genetics - metabolism - physiology |
3 |
serpins |
3 |
sexual behavior |
3 |
social hygiene clinic |
3 |
sox2 |
3 |
soxb1 transcription factors - genetics - metabolism |
3 |
staging |
3 |
stress, psychological - etiology |
3 |
tcf/lef-1 |
3 |
telomerase activity |
3 |
telomere |
3 |
terminal deoxynucleotidyl transferase (tdt)-mediated deoxyuracil triphosphate (dutp) nick-end labelling (tunel) |
3 |
timp3 |
3 |
tissue array |
3 |
tissue polypeptide antigen |
3 |
tp53 |
3 |
traditional chinese medicine |
3 |
transition |
3 |
transitional cell carcinoma |
3 |
trkb |
3 |
trophoblastic disease |
3 |
trophoblastic neoplasms - complications - drug therapy - surgery |
3 |
trophoblastic neoplasms - diagnosis - immunology |
3 |
trophoblastic neoplasms - genetics |
3 |
trophoblastic tumor, placental site - metabolism - pathology |
3 |
trophoblasts - metabolism - physiology |
3 |
tumor debulking |
3 |
tumor microenvironment |
3 |
tumor suppressor protein p53 - metabolism |
3 |
tumor suppressor proteins - genetics - metabolism - physiology |
3 |
tumor virus infections - epidemiology |
3 |
tumor virus infections - epidemiology - mortality |
3 |
tumor-associated macrophages |
3 |
tumor-suppressor-protein-p53-genetics |
3 |
tumor-suppressor-protein-p53-metabolism |
3 |
tumorigenicity |
3 |
ultrasonography |
3 |
uterine anomaly |
3 |
uterine cervical diseases - epidemiology |
3 |
uterine cervical neoplasms - diagnosis - genetics |
3 |
uterine cervical neoplasms - diagnosis - pathology |
3 |
uterine cervical neoplasms - drug therapy - pathology - radiotherapy |
3 |
uterine cervical neoplasms - epidemiology - pathology - surgery |
3 |
uterine cervical neoplasms - ethnology - virology |
3 |
uterine cervical neoplasms - genetics - metabolism |
3 |
uterine cervical neoplasms - genetics - mortality - pathology - radiotherapy |
3 |
uterine cervical neoplasms - genetics - virology |
3 |
uterine cervical neoplasms - metabolism |
3 |
uterine cervical neoplasms - metabolism - mortality - virology |
3 |
uterine cervical neoplasms - microbiology |
3 |
uterine cervical neoplasms - pathology - radiotherapy - surgery |
3 |
uterine cervical neoplasms - prevention and control - virology |
3 |
uterine cervical neoplasms - psychology |
3 |
uterine cervical neoplasms - virology |
3 |
uterine cervix cancer |
3 |
uterine neoplasms - blood - complications - drug therapy - surgery |
3 |
uterine neoplasms - diagnosis - immunology |
3 |
uterine neoplasms - diagnosis - pathology |
3 |
uterine neoplasms - genetics |
3 |
uterine neoplasms - pathology - therapy |
3 |
uterus - abnormalities - pathology |
3 |
vagina |
3 |
vaginal intraepithelial neoplasia |
3 |
vaginal neoplasms - epidemiology - pathology - radiotherapy - surgery |
3 |
vaginal neoplasms - pathology |
3 |
varian cancer |
3 |
viral load |
3 |
vulva |
3 |
vulvar neoplasms - epidemiology - pathology - radiotherapy - surgery |
3 |
wnt |
3 |
wnt/β-catenin |
3 |
women's health issues |
3 |
"favor neoplasia" |
2 |
"nos" |
2 |
'favor neoplasia' |
2 |
'nos' |
2 |
3d ultrasound |
2 |
adenocarcinoma - blood - pathology |
2 |
adenocarcinoma - diagnosis - pathology |
2 |
adenocarcinoma - diagnosis - pathology - physiopathology |
2 |
adenocarcinoma - etiology - metabolism |
2 |
adenocarcinoma - virology |
2 |
adenocarcinoma of cervix |
2 |
adenocarcinoma, mucinous - drug therapy - pathology |
2 |
adenosarcoma |
2 |
adenoviral vector |
2 |
agc |
2 |
agus |
2 |
ampk activator |
2 |
analysis of variance |
2 |
angiography |
2 |
antibiotics, antineoplastic - therapeutic use |
2 |
anticancer |
2 |
antigens, neoplasm - analysis |
2 |
antigens, neoplasm - blood |
2 |
antineoplastic agents - adverse effects - therapeutic use |
2 |
antioxidant activity |
2 |
antisense oligonucleotide |
2 |
apgar score |
2 |
arteries - surgery |
2 |
asia |
2 |
asia - epidemiology |
2 |
asia pacific |
2 |
asphyxia neonatorum - etiology |
2 |
atp cell viability assay |
2 |
attitudes |
2 |
bar |
2 |
bax/bcl-2 |
2 |
bcl-2 |
2 |
biopsy - statistics & numerical data |
2 |
birth injuries - etiology |
2 |
birth weight |
2 |
bitter melon |
2 |
bleomycin - administration & dosage - adverse effects |
2 |
breast carcinoma |
2 |
ca-19-9 antigen - blood |
2 |
ca15.3 |
2 |
ca19.9 |
2 |
cancers |
2 |
capsid proteins |
2 |
carboplatin - pharmacology |
2 |
carcinoembryonic antigen |
2 |
carcinoembryonic antigen - blood |
2 |
carcinoma in situ - diagnosis - epidemiology - etiology - pathology |
2 |
carcinoma in situ - diagnosis - pathology |
2 |
carcinoma of the cervix |
2 |
carcinoma of the ovary |
2 |
carcinoma, adenosquamous - diagnosis - pathology - physiopathology |
2 |
carcinoma, squamous cell - diagnosis - pathology - physiopathology |
2 |
carcinoma, squamous cell - epidemiology - genetics - virology |
2 |
carcinoma, squamous cell - epidemiology - prevention & control - virology |
2 |
carcinoma, squamous cell - mortality - pathology |
2 |
carcinoma,-squamous-cell-microbiology |
2 |
cell metabolism |
2 |
cell survival - drug effects |
2 |
cervical |
2 |
cervical cancer cell lines |
2 |
cervical carcinoma |
2 |
cervical intraepithelial neoplasia - diagnosis - epidemiology - etiology - pathology |
2 |
cervical intraepithelial neoplasia - diagnosis - pathology |
2 |
cervical intraepithelial neoplasia - pathology - therapy |
2 |
cervical intraepithelial neoplasia - prevention & control - psychology |
2 |
cervical intraepithelial neoplasia - prevention & control - virology |
2 |
cervix carcinoma |
2 |
cervix uteri - pathology |
2 |
cervix-uteri-microbiology |
2 |
chemotherapy, adjuvant - methods |
2 |
chinese adolescent girls |
2 |
choriocarcinoma - drug therapy - secondary |
2 |
choriocarcinoma - pathology - therapy |
2 |
chorionic villi |
2 |
cisplatin - administration & dosage |
2 |
cisplatin - administration & dosage - adverse effects |
2 |
clinical trials as topic |
2 |
combined modality therapy - methods |
2 |
complications |
2 |
consensus sequence |
2 |
conservative treatment |
2 |
consumer health information - methods |
2 |
cost |
2 |
cyclophosphamide |
2 |
cyclophosphamide - administration & dosage |
2 |
dexamethasone - administration & dosage - adverse effects |
2 |
dilatation and curettage |
2 |
dna, viral - analysis - genetics |
2 |
doxorubicin - administration & dosage - adverse effects |
2 |
drug screening assays, antitumor |
2 |
embolization, therapeutic |
2 |
endocrine system diseases - drug therapy - pathology |
2 |
endometrial and ovarian carcinomas |
2 |
endometrial hyperplasia - diagnosis - pathology |
2 |
endometrial neoplasms - diagnosis - surgery - therapy |
2 |
epidemiology |
2 |
epirubicin - therapeutic use |
2 |
erbb2 mutation |
2 |
esophageal neoplasms - epidemiology - genetics - virology |
2 |
esophagus |
2 |
extraction, obstetrical - instrumentation |
2 |
fear |
2 |
fertility preservation |
2 |
gene expression regulation, neoplastic - physiology |
2 |
gene transfer |
2 |
genes, bcl-2 |
2 |
genital neoplasms, female - complications |
2 |
genital neoplasms, female - pathology |
2 |
gestational trophoblastic disease - complications - epidemiology |
2 |
gestational trophoblastic disease - complications - psychology - therapy |
2 |
gestational trophoblastic meoplasia |
2 |
gestational trophoblastic neoplasms |
2 |
growth arrest and dna damage inducible protein 45 |
2 |
growth arrest and dna damage inducible protein 45 alpha |
2 |
growth arrest/apoptosis |
2 |
gynaecological cancers |
2 |
gynecological malignancy |
2 |
health personnel |
2 |
healthcare providers |
2 |
heart neoplasms - secondary |
2 |
hemorrhage - etiology |
2 |
hemostatic techniques - utilization |
2 |
high-dose cis-platinum |
2 |
histology |
2 |
hong kong chinese |
2 |
hpv dna |
2 |
hpv education |
2 |
human papillomavirus testing |
2 |
hydatidiform mole - blood |
2 |
hysterectomy - psychology |
2 |
intermediate filament proteins - metabolism |
2 |
intestinal metaplasia |
2 |
intracardiac tumor |
2 |
intravenous leiomyomatosis |
2 |
jaundice, neonatal - etiology |
2 |
keratin-20 |
2 |
keratin-7 |
2 |
kidney - drug effects |
2 |
kras mutation |
2 |
laser-captured micro-dissection |
2 |
leiomyoma - epidemiology - secondary |
2 |
leucovorin - administration & dosage - adverse effects |
2 |
ligation |
2 |
live fetus |
2 |
low grade squamous intraepithelial lesions (lsil) |
2 |
lung - drug effects - physiopathology |
2 |
lymph node excision |
2 |
lymphatic metastasis |
2 |
lymphocyst |
2 |
lymphoma, non-hodgkin - drug therapy - physiopathology |
2 |
malformation |
2 |
medical records |
2 |
medicinal fungi |
2 |
medicinal plants |
2 |
meta-analysis |
2 |
methotrexate - administration & dosage - adverse effects |
2 |
methyltransferase |
2 |
mitochondria |
2 |
mitochondrial dna alterations |
2 |
mitogen activated protein kinase kinase 4 |
2 |
mitomycin |
2 |
mitomycin c |
2 |
mitomycins - administration & dosage |
2 |
momordica charantia |
2 |
msp |
2 |
mucin-1 - blood |
2 |
neoplasm recurrence, local - therapy |
2 |
neoplasms, germ cell and embryonal - drug therapy - pathology |
2 |
neoplasms, multiple primary - pathology |
2 |
nervous system neoplasms - drug therapy - pathology |
2 |
nucleic acid hybridization |
2 |
nutraceuticals |
2 |
oncogene proteins, viral - genetics |
2 |
oncogene proteins, viral - isolation & purification |
2 |
organ sparing treatments |
2 |
ovarian |
2 |
ovarian neoplasms - drug therapy |
2 |
ovariectomy |
2 |
p21(waf1) |
2 |
palliation |
2 |
palliative care |
2 |
papillomaviridae-isolation-and-purification |
2 |
papillomavirus infections - complications - virology |
2 |
papillomavirus infections - epidemiology - prevention & control - virology |
2 |
papillomavirus infections - prevention & control - psychology |
2 |
papillomavirus infections - prevention and control |
2 |
papillomavirus vaccines - administration & dosage |
2 |
partial mole |
2 |
pathology review |
2 |
patient education as topic |
2 |
pcr |
2 |
pediatrics |
2 |
pelvic lymphadenectomy |
2 |
peptides - analysis |
2 |
persistent trophoblastic disease |
2 |
pik3ca mutation |
2 |
placental-site trophoblastic tumour |
2 |
plasma dna |
2 |
pleural effusion, malignant - etiology - therapy |
2 |
pleurodesis |
2 |
postpartum |
2 |
prb |
2 |
precancerous conditions - diagnosis - epidemiology - pathology - physiopathology |
2 |
prednisone - administration & dosage - adverse effects |
2 |
pregnancy complications, neoplastic - diagnosis - epidemiology - pathology - physiopathology |
2 |
protein p73 |
2 |
proto-oncogene proteins - genetics |
2 |
proto-oncogene proteins c-bcl-2 - genetics |
2 |
psychosocial study |
2 |
pulmonary diffusing capacity - drug effects |
2 |
pyrosequencing |
2 |
quantitative pcr |
2 |
radiography, interventional |
2 |
radioimmunoassay |
2 |
radiosensitivity |
2 |
radiotherapy - methods |
2 |
random allocation |
2 |
recurrence |
2 |
referral and consultation |
2 |
relapse |
2 |
remission, spontaneous |
2 |
respiratory function tests |
2 |
retroperitoneal neoplasms - pathology |
2 |
safety |
2 |
school-based health education |
2 |
selective |
2 |
self concept |
2 |
serum |
2 |
sexual functioning |
2 |
significant pathology |
2 |
singapore |
2 |
social stigma |
2 |
soft tissue neoplasms - epidemiology - secondary |
2 |
spot and early morning urine |
2 |
squamous cell carcinoma antigen |
2 |
sscp |
2 |
staining and labeling |
2 |
stigma |
2 |
taiwan |
2 |
targeted therapy |
2 |
therapeutic embolization |
2 |
tissue polypeptide antigen - blood |
2 |
toxicity |
2 |
tp53 mutation |
2 |
treatment |
2 |
trophoblastic neoplasms - blood |
2 |
trophoblastic neoplasms - drug therapy - secondary |
2 |
trophoblastic neoplasms - psychology |
2 |
trophoblastic tumor, placental site - genetics - pathology |
2 |
tumor markers, biological |
2 |
tumor markers, biological - analysis - blood |
2 |
tumor markers, biological - blood |
2 |
tumor virus infections - complications - virology |
2 |
tumor-suppressor-protein-p53-analysis |
2 |
tumour markers |
2 |
type distribution |
2 |
undifferentiated endometrial sarcoma |
2 |
urethral adenocarcinoma |
2 |
urethral neoplasms - etiology - metabolism |
2 |
urethral neoplasms - pathology |
2 |
urethritis - complications |
2 |
urethritis glandularis |
2 |
urinary hcg-beta-core |
2 |
uterine |
2 |
uterine bleeding |
2 |
uterine cervical dysplasia - pathology - therapy |
2 |
uterine cervical neoplasms - blood - pathology |
2 |
uterine cervical neoplasms - diagnosis - pathology - physiopathology |
2 |
uterine cervical neoplasms - drug therapy - mortality - radiotherapy |
2 |
uterine cervical neoplasms - epidemiology - prevention & control - virology |
2 |
uterine cervical neoplasms - ethnology - prevention and control - virology |
2 |
uterine cervical neoplasms - mortality - pathology |
2 |
uterine cervical neoplasms - pathology - therapy |
2 |
uterine hemorrhage - etiology - radiography - therapy |
2 |
uterine neoplasms - blood |
2 |
uterine neoplasms - complications - epidemiology |
2 |
uterine neoplasms - psychology |
2 |
uterine-cervical-neoplasms-microbiology |
2 |
vacuum extraction, obstetrical - adverse effects - instrumentation |
2 |
vagina - injuries |
2 |
vaginal metastases |
2 |
vaginal neoplasms - drug therapy - secondary |
2 |
vaginal smears - statistics & numerical data |
2 |
vena cava, inferior |
2 |
vincristine - administration & dosage - adverse effects |
2 |
young women |
2 |
9vhpv |
1 |
9vhpv vaccine |
1 |
actuarial analysis |
1 |
adenocarcinoma - chemistry |
1 |
adenocarcinoma - complications |
1 |
adenocarcinoma - drug therapy - pathology - surgery |
1 |
adenocarcinoma - radiotherapy |
1 |
age distribution |
1 |
aids |
1 |
amifostine |
1 |
anal cancer |
1 |
anthropometry |
1 |
anti-bacterial agents - therapeutic use |
1 |
antibiotic prophylaxis |
1 |
antigens, tumor-associated, carbohydrate - blood |
1 |
antimetabolites, antineoplastic - therapeutic use |
1 |
antineoplastic agents, phytogenic - therapeutic use |
1 |
anxiety |
1 |
anxiety - etiology - prevention & control |
1 |
apoptosis - radiation effects |
1 |
ascites - etiology |
1 |
asgo |
1 |
barriers to uptake |
1 |
biopsy, needle - methods |
1 |
birthweight |
1 |
bleomycin - therapeutic use |
1 |
body height |
1 |
body weight |
1 |
brachytherapy - adverse effects |
1 |
breast diseases - diagnosis |
1 |
breast neoplasms - pathology - therapy |
1 |
breech presentation |
1 |
ca cervix |
1 |
ca-125 |
1 |
cancer staging |
1 |
carcinoma - diagnosis - epidemiology - therapy |
1 |
carcinoma - diagnosis - genetics - prevention & control |
1 |
carcinoma - drug therapy - pathology - surgery |
1 |
carcinoma - radiotherapy |
1 |
carcinoma, ductal, breast - pathology |
1 |
carcinoma, squamous cell - blood - immunology - radiotherapy |
1 |
carcinoma, squamous cell - chemistry |
1 |
carcinoma, squamous cell - diagnosis - pathology |
1 |
carcinoma, squamous cell - drug therapy - pathology |
1 |
carcinoma, squamous cell - immunology |
1 |
carcinoma, squamous cell - radiotherapy |
1 |
catheterization - methods |
1 |
cervical biopsy |
1 |
cervical cancer control |
1 |
cervical cancer prevention |
1 |
cervical caner |
1 |
cervical intraepithelial neoplasia - pathology |
1 |
cervical intraepithelial neoplasia - prevention & control |
1 |
cervical punch biopsy |
1 |
cervix cancer |
1 |
cervix uteri - chemistry |
1 |
cesarean section |
1 |
chemosensitivity |
1 |
chemotherapy, adjuvant |
1 |
child |
1 |
choriocarcinoma - pathology |
1 |
chorionic gonadotropin, beta subunit, human - blood |
1 |
classification |
1 |
clinical trial |
1 |
clinical trials |
1 |
colposcopy - methods - psychology |
1 |
communication |
1 |
complementary and alternative medicine |
1 |
contraception |
1 |
cost-benefit analysis |
1 |
cost-effective |
1 |
counseling |
1 |
counselling |
1 |
ct |
1 |
ct thorax |
1 |
cystadenocarcinoma - drug therapy - pathology - surgery |
1 |
cytodiagnosis - instrumentation |
1 |
cytotoxicity |
1 |
dactinomycin - administration & dosage |
1 |
dactinomycin - therapeutic use |
1 |
diagnosis |
1 |
doppler sonography |
1 |
dose-response relationship, radiation |
1 |
drainage - methods |
1 |
drug response |
1 |
embryonic and fetal development |
1 |
endometrial hyperplasia - pathology |
1 |
endometrial neoplasms |
1 |
endometrial neoplasms - pathology - surgery |
1 |
endometriosis - complications |
1 |
endometriosis - drug therapy - pathology - surgery |
1 |
endometrium - pathology |
1 |
epirubicin - adverse effects - therapeutic use |
1 |
epithelioid trophoblastic tumor |
1 |
etoposide - therapeutic use |
1 |
excision |
1 |
exenteration |
1 |
extraction, obstetrical - adverse effects |
1 |
extrauterine involvement |
1 |
fertility |
1 |
fetal death |
1 |
fetal growth retardation - diagnosis |
1 |
fetal membranes, premature rupture - complications |
1 |
fetus - anatomy & histology |
1 |
fever - prevention & control |
1 |
figo |
1 |
figo cancer report |
1 |
fluorouracil - administration & dosage |
1 |
folinic acid rescue |
1 |
genital neoplasms, female - classification - pathology |
1 |
genital warts |
1 |
geometric mean titers (gmts) |
1 |
gestational trophoblastic disease - diagnosis - pathology - radiography - therapy |
1 |
gestational trophoblastic disease - drug therapy - metabolism |
1 |
gestational trophoblastic tumor (gtt) |
1 |
glycosylation |
1 |
gtn |
1 |
gynecologic cancer patients |
1 |
hcg |
1 |
health education - organization & administration - trends |
1 |
health personnel - education |
1 |
health policy - trends |
1 |
health services accessibility - trends |
1 |
health-care professionals |
1 |
heart diseases - chemically induced |
1 |
height |
1 |
hemoperitoneum - etiology |
1 |
hepatic arteriogram (hag) |
1 |
hiv screening |
1 |
hpv vaccines |
1 |
human papillomavirus vaccine |
1 |
human rights |
1 |
hydatidiform mole - diagnosis |
1 |
hydatidiform mole - drug therapy |
1 |
infant mortality |
1 |
infant, low birth weight |
1 |
infant, small for gestational age |
1 |
infusions, intravenous |
1 |
intellectual disability - etiology |
1 |
intelligence |
1 |
key words: |
1 |
klf2 |
1 |
liver metastasis |
1 |
liver neoplasms - blood supply - radiography - secondary - therapy |
1 |
low-risk gestational trophoblastic disease |
1 |
maintenance therapy |
1 |
malaysia |
1 |
malignant mixed mullerian tumors |
1 |
malignant trophoblastic disease |
1 |
maternal age |
1 |
maternal health services - organization & administration - trends |
1 |
medical records systems, computerized - statistics and numerical data |
1 |
menopause - metabolism |
1 |
metastases |
1 |
methotrexate - therapeutic use |
1 |
methotrexate infusion |
1 |
mgtd |
1 |
micrometastasis |
1 |
moles |
1 |
monitoring |
1 |
monitoring, immunologic - economics - methods |
1 |
monitoring, physiologic |
1 |
monsel's solution |
1 |
mothers - psychology |
1 |
mr imaging |
1 |
myelotoxicity |
1 |
neoplasm recurrence, local - drug therapy |
1 |
neoplasm recurrence, local - immunology |
1 |
neoplasm recurrence, local - prevention & control |
1 |
neoplasm staging - classification |
1 |
neoplasm staging - methods |
1 |
neoplasms, glandular and epithelial - diagnosis - genetics - prevention & control |
1 |
neurologic examination |
1 |
neutropenia |
1 |
obstetric labor complications - diagnosis - etiology |
1 |
occult cancer |
1 |
ovarian neoplasms - blood - drug therapy - surgery |
1 |
ovarian neoplasms - classification - diagnosis - mortality - therapy |
1 |
ovarian neoplasms - complications |
1 |
ovarian neoplasms - diagnosis - genetics - prevention & control |
1 |
ovarian neoplasms - diagnosis - pathology - therapy |
1 |
ovarian neoplasms - drug therapy - pathology - surgery |
1 |
ovarian tumors of low malignant potential |
1 |
papillomavirus infections - complications - genetics |
1 |
papillomavirus infections - prevention & control |
1 |
papillomavirus vaccines - immunology |
1 |
patient compliance |
1 |
pazopanib |
1 |
pelvic exenteration |
1 |
pelvic ultrasound |
1 |
pelvis |
1 |
penile cancer |
1 |
peritoneal cytology |
1 |
persistent trophoblastic tumour (pit) |
1 |
physician-patient relations |
1 |
physicians |
1 |
platinum-resistant epithelial ovarian cancer |
1 |
postoperative period |
1 |
pregnancy complications, neoplastic |
1 |
pregnancy outcome |
1 |
premenopause |
1 |
progression-free survival |
1 |
proportional hazards models |
1 |
psychomotor performance |
1 |
public health education |
1 |
puerperal disorders - etiology |
1 |
pulsatile flow |
1 |
radiation monitoring - methods |
1 |
radio-therapy |
1 |
radiotherapy |
1 |
radiotherapy dosage |
1 |
radiotherapy, adjuvant |
1 |
radium - adverse effects |
1 |
receptors, estrogen - analysis |
1 |
receptors, progesterone - analysis |
1 |
recurrent ovarian cancer |
1 |
recurrent respiratory papillomatosis |
1 |
registries |
1 |
regression analysis |
1 |
remission induction |
1 |
reoperation |
1 |
reproductive performance |
1 |
republic of korea |
1 |
review |
1 |
sarcoma - pathology - therapy |
1 |
scc |
1 |
second opinion |
1 |
serum human chorionic gonadotrophin (hcg) monitoring |
1 |
skinfold thickness |
1 |
stage ia pgtd |
1 |
struma ovarii |
1 |
suction |
1 |
suction - methods |
1 |
suppuration - therapy |
1 |
survey |
1 |
teratoma - drug therapy |
1 |
thailand |
1 |
tomography, x-ray computed |
1 |
topotecan |
1 |
transcriptional regulation |
1 |
treatment of vain |
1 |
trophoblastic neoplasms - blood - diagnosis - drug therapy |
1 |
trophoblastic neoplasms - blood supply - drug therapy - ultrasonography |
1 |
trophoblastic neoplasms - pathology |
1 |
trophoblastic neoplasms - physiopathology - psychology |
1 |
trophoblastic tumor, placental site - radiography - ultrasonography |
1 |
tumor suppressor proteins - genetics - metabolism |
1 |
ultrasonography, doppler, color |
1 |
umbilical cord |
1 |
univariate & multivariate analysis |
1 |
urban population |
1 |
uterine cervical neoplasms - blood - drug therapy - immunology |
1 |
uterine cervical neoplasms - blood - immunology - radiotherapy |
1 |
uterine cervical neoplasms - chemistry |
1 |
uterine cervical neoplasms - drug therapy - pathology |
1 |
uterine cervical neoplasms - immunology |
1 |
uterine cervical neoplasms - mortality - pathology - therapy |
1 |
uterine cervical neoplasms - mortality - therapy |
1 |
uterine cervical neoplasms - pathology - radiotherapy |
1 |
uterine cervical neoplasms - prevention & control |
1 |
uterine cervical neoplasms - radiotherapy |
1 |
uterine diseases - therapy |
1 |
uterine hemorrhage - etiology |
1 |
uterine neoplasms - blood - diagnosis - drug therapy |
1 |
uterine neoplasms - blood supply - drug therapy - ultrasonography |
1 |
uterine neoplasms - diagnosis - epidemiology - therapy |
1 |
uterine neoplasms - pathology |
1 |
uterine neoplasms - physiopathology - psychology |
1 |
uterus - blood supply |
1 |
vaccination |
1 |
vaccine |
1 |
vacuum extraction, obstetrical - adverse effects |
1 |
vagina - pathology |
1 |
vaginal bleeding |
1 |
vaginal cancer |
1 |
vaginal diseases - therapy |
1 |
vaginal neoplasms - classification - diagnosis - mortality - therapy |
1 |
vaginal sarcoma |
1 |
vaginal stenosis |
1 |
vaginal-template implant |
1 |
value of life |
1 |
vincristine - administration & dosage |
1 |
vulval cancer |
1 |
vulvar neoplasms - pathology - therapy |
1 |
wee1 |
1 |
weight |
1 |
women over 25 years |
1 |
women's rights |
1 |
women's rights - education - trends |
1 |
workshop |
1 |